Skip to content

General Anesthesia exposure and neurodevelopmental outcome in Pediatric

GAP-trial: General Anesthesia exposure and neurodevelopmental outcome in Pediatric

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON26844
Enrollment
70
Registered
2020-10-02
Start date
2020-10-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgeries related to dDuodenal-jejunal-ileal atresia repairs, anorectal malformation, Hirschsprung disease and/or inguinal hernia

Interventions

None listed

Sponsors

Emma Children’s Hospital, Amsterdam UMC.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: age 12 months (± four weeks) with a history of general anesthesia exposure (patient group) or without a history of general anesthesia (healthy controls)

Exclusion criteria

Exclusion criteria: Children with comorbid conditions affecting structure and/or function of the central nervous system (e.g. premature birth) will be excluded from participation in this study.

Design outcomes

Primary

MeasureTime frame
Neurocognitive development as measured using eye-tracking metrics

Secondary

MeasureTime frame
a. Conventional measures of neurocognitive development (Ages & Stages Questionnaire and Bayley Scales of Infant Development ) b. Total anesthesia time. Surgery and anesthesia time will be recorded by the (fellow) surgeon performing the operation(s). When multiple procedures are carried out, durations will be combined and these results will be retrieved during analysis of the data.

Contacts

Public ContactSanne Maat

Amsterdam UMC

s.c.maat@amsterdamumc.nl0641453392

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)